Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants

NCT02641041 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Nervous System (CNS) Demyelinating Disease
Multiple Sclerosis

Interventions

BIOLOGICAL: BIIB033
OTHER: Placebo

Sponsor

Biogen